Skip to content

Omeros

US · OMER #3062 by market cap Listed 1970
13.21 -0.80 -5.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 7 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.6 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
51.39% +0.60pp
Institutions
205 +7
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund43.00%
Hedge Fund4.56%
Individual/Insider4.29%
Public Company2.12%
Private Company0.83%
Insurance Company0.38%
Government Pension Fund0.32%
Other44.33%

Top holders as of 2026-09-30

BlackRock 8.35% · 6.05M sh
Ingalls & Snyder, LLC 5.06% · 3.66M sh
Vanguard Capital Management, LLC 4.22% · 3.06M sh
UBS Asset Management 4.18% · 3.02M sh
State Street Global Advisors 3.10% · 2.24M sh
Geode Capital Management, LLC 2.62% · 1.90M sh
Stifel Asset Management Corp. 2.54% · 1.84M sh
Gregory Demopulos 2.03% · 1.47M sh
Federated Hermes, Inc. 1.43% · 1.03M sh
Peter Demopulos 1.34% · 972.90K sh
Vanguard Portfolio Management, LLC 1.33% · 962.83K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

49 filings tracked · 35 buys · 11 sells

NameRoleStake
Gregory Demopulos Chairperson & CEO 2.03%
Peter Demopulos Director 1.34%
Joseph Schocken Director 0.73%
Leroy Hood Independent Director 0.10%
Thomas Cable Lead Independent Director 0.05%
Arnold Hanish Independent Director 0.02%
Thomas Bumol Independent Director 0.01%
Peter Cancelmo General Counsel 0.00%
Rajiv Shah Independent Director --
Diana Perkinson Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-27 Gregory Demopulos Chairperson & CEO Other Derivative Acquisition +500,000 $17.88
2026-09-22 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -20,000 $2.94–20.95
2026-08-30 Peter Cancelmo General Counsel Derivative Exercise and Sale -50,000 $2.94–18.65
2026-08-26 Arnold Hanish Independent Director Derivative Exercise and Sale -15,000 $14.66–19.02
2026-08-23 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -10,906 $2.94–19.10
2026-08-19 Thomas Cable Lead Independent Director Derivative Exercise and Sale -15,000 $2.00–18.45
2026-08-12 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -5,000 $3.93–16.95
2026-08-11 Joseph Schocken Director Other Derivative Acquisition +30,000 $13.71
2026-08-11 Joseph Schocken Director Initial Statement of Beneficial 0 --
2026-07-21 Gregory Demopulos Chairperson & CEO Other Derivative Acquisition +1,000,000 $9.84
2026-07-21 Peter Cancelmo General Counsel Other Derivative Acquisition +105,000 $9.84
2026-07-21 David Borges VP of Finance, Chief Accounting Officer & Treasurer Other Derivative Acquisition +105,000 $9.84
2026-06-17 Thomas Cable Lead Independent Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Leroy Hood Independent Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Arnold Hanish Independent Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Peter Demopulos Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Thomas Bumol Independent Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Rajiv Shah Independent Director Other Derivative Acquisition +15,000 $10.28
2026-06-17 Diana Perkinson Independent Director Other Derivative Acquisition +15,000 $10.28
2026-05-21 Thomas Cable Lead Independent Director Derivative Exercise and Sale -7,500 $10.84–11.61

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.

Omeros discussion 0 comments

Add a comment